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ABSTRACT
Introduction An increasing number of people who have 
a history of acute coronary syndrome or cerebrovascular 
accident (termed cardiovascular events) are being considered 
for surgery. Up- to- date evidence of the impact of these prior 
events is needed to inform person- centred decision making. 
While perioperative risk for major adverse cardiac events 
immediately after a cardiovascular event is known to be 
elevated, the duration of time after the event for which the 
perioperative risk is increased is not clear.
Methods and analysis This is an individual patient- level 
database linkage study of all patients in England with at least 
one operation between 2007 and 2017 in the Hospital Episode 
Statistics Admitted Patient Care database. Data will be linked 
to mortality data from the Office for National Statistics up 
to 2018, for 30- day, 90- day and 1- year mortality and to the 
Myocardial Ischaemia National Audit Project, a UK registry of 
acute coronary syndromes. The primary outcome will be the 
association between time from cardiovascular event to index 
surgery and 30- day all- cause mortality. Additional associations 
we will report are all unplanned readmissions, prolonged length 
of stay, 30- day hospital free survival and incidence of new 
cardiovascular events within one postoperative year. Important 
subgroups will be surgery specific (invasiveness, urgency and 
subspecialty), type of acute coronary syndrome (ST or non- ST 
elevation myocardial infarction) and type of cerebrovascular 
accident (ischaemic or haemorrhagic stroke).
Ethics and dissemination Ethical approval for this 
observational study has been obtained from East 
Midlands—Nottingham 1 Research Ethics Committee; REC 
reference: 18/EM0403. The results of the study will be 
made available through peer- reviewed publications and via 
the Health Services Research Centre of the Royal College 
of Anaesthetists, London.
INTRODUCTION
Cardiovascular events are recognised risk 
factors for perioperative morbidity and 
mortality.1–3 However, the original data on 
Strengths and limitations of this study
 ► This is the largest database linkage study to date on 
perioperative outcomes as related to prior cardio-
vascular events.
 ► Use of robust data sources (Hospital Episode Statistics, 
Office for National Statistics and Myocardial Infarction 
National Audit Project) comprised of national, prospec-
tively collected data reflects overall current clinical prac-
tice and is not limited to clinical trial patients therefore 
making the results more generalisable.
 ► There is not the clinical equipoise to randomise patients 
with prior cardiovascular events to surgery or not, espe-
cially on the scale of this study looking at all non- cardiac 
non- neurologic surgery over a period of 10 years.
 ► This study will produce models for time- dependent 
perioperative risk in patients with a history of cardio-
vascular events addressing an identified gap in the 
evidence.
 ► The study is limited by including only people with a 
known previous cardiovascular event in the registries 
used, with the potential to miss those in whom their car-
diovascular risk status is unknown.
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cerebrovascular accidents (stroke) and acute coronary 
syndrome (ACS) supporting this assertion are increas-
ingly less relevant to current medical practice: treatment 
of stroke and ACS along with the resultant prognoses 
have improved significantly. The Myocardial Infarction 
National Audit Project (MINAP) has demonstrated the 
use of primary percutaneous coronary intervention for 
ST- elevation myocardial infarction in England has risen 
from 82% to 99.3%, in eligible patients, from 2011 to 
2016.4 UK and European data show crude 30- day mortality 
has fallen from 12.4% to 9.07% in MINAP (2003 to 2018) 
and from 15.8% to 9.2% in SWEDEHEART (1995 to 
2014).5–7 From 1999–2008 the crude 56- day mortality 
from stroke has fallen from 21% to 12%,8 though it has 
not fallen significantly since.9 As a consequence, surgery 
is being offered to patients with comorbidities previously 
felt to be significantly high risk or to preclude surgery 
completely.10 11
The duration of time for which risk is increased after a 
cardiovascular event (ACS or stroke) is based on limited 
evidence,12 13 nor is it well known which characteristics of 
the event or which treatments received at the time may 
be predictive of an adverse perioperative outcome in the 
future. This study will ascertain at an individual patient 
level the strength of any time- dependent association 
between preoperative cardiovascular events and postop-
erative mortality, as well as the occurrence of any postop-
erative major adverse cardiovascular events (MACE). Our 
aim in the ‘Cerebrovascular accident and Acute coronary 
syndrome and Perioperative Outcomes’ (CAPO) study is 
to perform a database linkage between the HES, MINAP 
and ONS databases for all adult patients who have had 
non- cardiac, non- neurosurgical operations with NHS 
funding between 2007 and 2017 in hospitals in England.
It will represent, to the best of our knowledge, the 
largest study of the time- dependent nature of adverse 
perioperative outcomes in patients with a known cardio-
vascular risk factor. We are prospectively publishing our 
methodology to openly prespecify our study population 
and statistical analysis plan.
METHODS AND ANALYSIS
Study design
This is a longitudinal observational cohort study of 
patients undergoing surgery between 2007 and 2017. All 
data to be analysed have been prospectively collected as 
part of one of the several national registries. We have data 
sharing agreements and ethical approval to individually 
link data for all patients who have had NHS commis-
sioned surgery in any hospital in England between these 
dates in the Hospital Episode Statistics (HES) Admitted 
Patient Care (APC) data set to mortality data from the 
Office for National Statistics (ONS), to those who have 
had ACS captured in the MINAP from 2003 onwards (the 
start of MINAP data collection). Patients with a cardiovas-
cular event in the 10 years preceding their index surgery, 
or within one postoperative year, will be identified in HES 
APC as well as MINAP. This is described schematically in 
figure 1.
Data sources
HES APC data set: This is a national registry database 
containing details of all admissions to NHS hospitals in 
England. Each HES record contains clinical informa-
tion about diagnoses and operations, as well as patient, 
administrative and geographical information. HES data 
have been available since 1989. NHS Digital is the data 
controller. We will first identify all patients with a preop-
erative or postoperative stroke or ACS, in the 10 years 
preceding index surgery and 1 year postsurgery, from the 
entire cohort who had surgery between 2007 and 2017. 
The most recent cardiovascular event preceding the 
index surgery will be used for calculating the time interval 
in the primary outcome. This data set will be from HES 
APC 1997 to 2018.
ONS: The ONS mortality data contain information 
related to a person’s death taken from the death certifi-
cate for all deaths registered in England and Wales. NHS 
Digital is the data controller. This will be the source of 
mortality data for primary outcome analysis. This will be 
ONS data from 2007 to 2018.
MINAP: This is a national cardiac clinical audit 
that collects information to measure the process and 
outcomes of care of every patient diagnosed with a 
myocardial infarction in the UK.14 MINAP data are avail-
able from 2003. The National Institute for Cardiovascular 
Outcomes Research (NICOR) is the data processor and 
Healthcare Quality Improvement Partnership is the data 
controller. This will be the MINAP data set from 2003 to 
2018.
MINAP will serve as a secondary method for identifying 
preoperative and postoperative ACS and as the primary 
method for obtaining specific treatments of the preopera-
tive ACS events and the pathophysiologic data as detailed 
in the predictor measurements below.
The MINAP case ascertainment rate is well documented 
in an accompanying document for annual reports. It high-
lights the continued trend from their previous reports 
that non- ST elevation myocardial infarction (NSTEMI) 
Figure 1 Schematic of study design. Schema to represent 
the time periods of interest for the overall study from data 
collection of patient risk factors 10 years prior to their first 
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events are underreported whereas there is near complete 
capture of ST- elevation myocardial infarction (STEMI; 
which they can reliably cross reference to the NICOR 
Adult Coronary Intervention Audit. This report also 
demonstrates some of the data discrepancies between 
HES and MINAP registries.15 16
There is a similar national registry for stroke with data 
from 2012 onwards that is analogous to MINAP. The 
programme was approached but declined to provide 
the requested data for the linkage study during the data- 
linkage window.
Data linkage
NHS Digital will perform rule- based linkage between 
these data sets using the following record level indica-
tors: NHS numbers (unique identifier assigned at birth 
or during first contact with NHS care), date of birth, 
postcode and sex. Once the databases are linked, they 
perform the pseudoanonymisation process to enable 
transfer to our institution for analysis.
Data set cleaning
The data in the HES APC undergo a documented 
cleaning process prior to linkage.17 After the linkage of 
NHS Digital’s HES APC and ONS to HQIP’s MINAP data 
set, the data will be further cleaned to identify duplicates, 




All patients aged ≥18 years of age on the day of surgery 
with an attendance to hospital in the HES APC data set 
between 2007 and 2017 for an operative procedure are 
identified using the OPCS-4 codes for surgical proce-
dures, HES APC ‘admission date’ and HES APC ‘age on 
admission’ fields. From this, we will identify patient’s first 
surgical episode within the study window which will act as 
the index surgical event. The patient’s first operation will 
used in the primary outcome measure.
Patients with a history of ACS or stroke (termed cardio-
vascular events) in the 10 years preceding this index 
surgical event will be defined according to their primary 
diagnosis ICD-10 codes in HES APC and further ACS case 
identification will occur using with MINAP specific codes 
(online supplemental appendix 1).
To assess the effect of operative severity, a classification 
based on OPCS-4 codes taking an inclusive, interme-
diate and restrictive interpretation of the surgical inva-
siveness will be used as already described by others.18 
For subgroup analysis of outcomes, we also classify oper-
ations by surgical type such as major lower limb joint 
replacement, vascular, gastrointestinal, gynaecological, 
urological, ENT, ophthalmological and breast surgery 
(online supplemental appendix 2). For each of these 
types of surgery, we will take each patient’s first opera-
tion within a defined subgroup. Sensitivity analysis will 
also be performed comparing that analysis by taking the 
patient’s last operation within the same subgroup. There 
are key operative categories for exclusion: cardiac, neuro-
surgical, carotid endarterectomy, obstetrics, tracheos-
tomy and percutaneous gastrostomy as identified using 
their OPCS-4 codes (online supplemental appendix 2). 
The decision to exclude cardiac surgery was on the basis 
of a pre- existing subspecialty specific risk prediction tool 
EuroSCORE II, thus reducing the need to investigate this 
population. The lack of specificity within ICD-10 codes 
also means it is not possible to identify type III- V myocar-
dial infarctions, therefore the results may be unreliable in 
this specific patient population. Neurosurgery and carotid 
endarterectomy are excluded based on the recognised 
high stroke risk specific to these surgeries.19 Both percu-
taneous gastrostomy insertion and tracheostomy forma-
tion were excluded due to a frequent indication for them 
being poststroke bulbar dysfunction. Obstetric surgical 
procedures are outside the scope of this study.
Validation studies of codes/algorithms
The use of HES APC data for identifying patients with 
the preoperative cardiovascular events as risk factors and 
linking this to ONS data for mortality has already been 
robustly demonstrated.20 NHS Digital (HES) and the ONS 
openly publish how their databases are regularly checked 
to ensure accuracy of the recorded data, and their methods 
of data cleaning and quality assurance.17 21 To the best of 
our knowledge, this is the first time MINAP will have been 
combined with surgical fields of HES and there are there-
fore no pre- existing data on the linkage of MINAP to HES 
and ONS databases for perioperative outcome measures. 
The use of OPCS-4 codes for identifying severity of surgical 
insult has already been well described.18
Variables
Exposures
The primary exposure will be the time interval between 
the most recent preoperative cardiovascular event and 
index surgery, identified from the 10- year HES data set. 
MINAP will be the secondary source of identifying ACS 
events. Table 1 describes how the exposures of interest 
are identified from the registries. Where this is detailed 
further, information is provided in the appendices.
Time between preoperative cardiovascular event and 
surgery will be fitted as a continuous variable for the primary 
outcome. Additionally, we will provide the time between 
preoperative event and surgery as categorical data using 
thresholds at 30 days, 90 days, 6 months and 1 year. The 
treatment of time as categorical data is to provide clinically 
meaningful risk intervals in addition to the robust contin-
uous data. These intervals are chosen to allow comparison 
with the time intervals currently used in clinical practice to 
delineate time thresholds of increased perioperative risk in 
those with a preoperative history of a cardiovascular event, 
and for comparison to existing publications.3 12 Restricted 
splines will be used for the time between preoperative 
cardiovascular event and index surgery in the logistic 
regression model as necessary.
copyright.
 on O












pen: first published as 10.1136/bm





4 Luney MS, et al. BMJ Open 2020;10:e037904. doi:10.1136/bmjopen-2020-037904
Open access 
Outcomes
The combined HES- MINAP data set will link to the 
ONS dates of death to 1 year after surgery. The primary 
outcome is the association between the time interval from 
preoperative cardiovascular event to index surgery and 
30- day all cause postoperative mortality.
The secondary outcomes are mortality at other time 
points, length of stay and cardiovascular events after 
surgery as described in table 2.
For length of stay calculations, we will use the same 
process already well described elsewhere.22 23 In brief, 
HES APC data codes admissions in the form of multiple 
finished consultant episodes where transfer of care 
between consultants generates a new episode. The 
conventional concept of an admission to hospital is 
termed a ‘spell’ in HES APC data and represents contig-
uous Finished Consultant Episodes. A ‘super- spell’ is 
the concept of incorporating an admission that spans 
episodes at multiple hospital trusts which we will use 
when calculating the total length of stay.
Exploratory analysis on postoperative recovery will 
comprise of measuring the proportion of days alive and 
out of hospital up to 30 days postoperatively.24 These will 
only be hypothesis generating and reported separately 
from the above outcomes.
Confounding
The potential confounders in all patients from HES APC 
that will be included as covariates in the modelling are: 
age, sex, deprivation index decile (‘Index of Multiple 
Deprivation’), ethnicity, comorbidities (using ICD-10 
codes for hypertension, atrial fibrillation, stable angina, 
peripheral vascular disease, valvular heart disease, 
congestive heart failure, respiratory failure, diabetes 
mellitus, renal failure, cancer and liver disease as per 
table 3), year of surgery and hospital provider (to account 
for clustering of patients within hospitals). The depriva-
tion index used by HES is ‘Index of Multiple Depriva-
tion’.25 The Charlson Comorbidity Index will be also be 
calculated as described in online supplemental appendix 
3.26 For people with MINAP data, additional predictors 
will be included in our models as detailed in table 4.
Selection bias
HES data are recorded by coders specifically trained in 
recording of healthcare related data based on clinical 
records. NHS Digital (HES APC) and ONS mortality 
data involve quality assurance processes and these are 
published quarterly on their websites.17 21
Sample size
The proportion of people undergoing surgery with a 
previous cardiovascular event has been shown to be 2.7% 
for ACS and 0.7% for stroke in a UK study of elective joint 
arthroplasty,20 and from 1.5% to 5% for stroke in interna-
tional studies of elective non- cardiac operations.13 27 The 
number of intermediate category operations is estimated 
to be 44 million over 10 years extrapolating from work by 
Abbott and colleagues.18 Using a conservative estimate 
of 30- day mortality of 1.02% (table 5), there would be 
approximately 450 000 deaths in the study.
Table 2 Adverse perioperative outcomes to be measured 




Death within 30 days ONS Primary outcome
Death within 90 days
Death within 60 days
Death within 1 year
Readmission ≤30 days HES
Prolonged* length of stay
Hospital free survival 
30 days
CVA within 1 year of 
surgery
Excluding TIA




Including UA and 
NSTEMI
AMI within 1 year of 
surgery
Including STEMI and 
NSTEMI
*Prolonged defined as a length of stay above the national upper 
quartile for the calendar year of index surgery, where>100 cases 
were performed per annum).
ACS, acute coronary syndrome; AMI, Acute myocardial 
infarction; CVA, cerebrovascular accident; HES, Hospital 
Episode Statistics; MINAP, Myocardial Infarction National Audit 
Project; NSTEMI, non- ST elevation myocardial infarction; STEMI, 
ST- elevation myocardial infarction; TIA, transient ischaemic 
attack; UA, unstable angina.
Table 1 Exposures to identify patients for inclusion in 
the models based on their diagnostic criteria and the data 




Myocardial infarction HES I21+22
MINAP See online supplemental 
appendix 1
  STEMI HES and 
MINAP
See online supplemental 
appendix 1  NSTEMI
Unstable angina
Stroke (CVA) HES I61, 63, 64
  Ischaemic stroke I63




*ICD-10 codes only, MINAP specific coding in online 
supplemental appendix 1.
CVA, cerebrovascular accident; HES, Hospital Episode Statistics 
Hospital Acute Patient Care; ;MINAP, Myocardial Infarction 
National Audit Project; NSTEMI, non- ST elevation myocardial 
infarction; STEMI, ST elevation myocardial infarction.
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For the a priori subgroup of total hip and knee arthro-
plasty, where annual numbers are around 100 000 and 
mortality is 0.2% at 30 days, approximately 2000 deaths 
would be observed. Taking the heuristic for logistic 
regression of 10 events per predictor, this would allow 
analysis of greater than 100 predictors.
While this could be considered an overpowering 
for the study to detect mortality differences in elective 
arthroplasty patients, it is necessary to power the study 
to detect differences in less frequently performed opera-
tions wherein the patient population is much smaller but 
the importance of cardiovascular burden of disease is still 




Primary analysis will be undertaken using logistic regression 
modelling for the association between the time interval 
from the most recent preoperative cardiovascular event to 
index surgery, and the postoperative 30- day mortality.
Control for confounding
The procedure for logistic regression will follow estab-
lished guidelines and the covariates are summarised 
above in tables 3 and 4.28 Models will account for the clus-
tering of patients within hospitals using random hospital- 
level effects as necessary.29 Model performance will be 
summarised using receiver operating characteristic curve 
concordance statistic, calibration plots and Brier scores.
Subgroup analysis
Secondary analyses will use logistic regression analysis to 
address the following subgroups a priori. The invasive-
ness of surgery and the surgical specialty will be used to 
form subgroups as well as surgical urgency (elective and 
emergency). The categorisation of surgery is described in 
detail in online supplemental appendix 2. For those with 
prior ACS, analysis will be between STEMI and NSTEMI; 
unstable angina will be excluded. In patients with preop-
erative history of stroke, the subgroups will be ischaemic 
or haemorrhagic stroke; transient ischaemic attacks will 
be excluded. Additionally, subgroups will analyse those 
Table 3 Characteristics general to all surgical patients with 
a history of cardiovascular for inclusion in the models as 












See online supplemental 
appendix 3
Hypertension ICD-10 codes (see online 













HES, Hospital Episode Statistics.
Table 4 Characteristics specific to patients with a 
preoperative ACS event for inclusion in the models as 























*Reperfusion treatments as a predictor will have the 
following levels: primary percutaneous coronary intervention, 
thrombolysis, urgent coronary artery bypass graft and none.
ACS, acute coronary syndrome; MINAP, Myocardial Infarction 
National Audit Project; NSTEMI, non- ST elevation myocardial 
infarction.
Table 5 Perioperative UK mortality data 2009–2014 





6.8 million 4.4 million 1.3 million
Mortality
30 days 1.10% 1.02% 1.50%
60 days 1.77% 1.57% 2.24%
90 days 2.31% 2.02% 2.83%
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with more than one preoperative cardiovascular event: 
multiple ACS events as compared with one ACS event, 
multiple strokes as compared with one stroke, and those 
with both ACS and stroke as compared with only one of 
ACS or stroke.
Variables in the regression models will include all 
comorbidities on surgical admission, patient demo-
graphics of age, deprivation index and ethnicity. Survival 
analysis will be used where continuous time- to- death data 
are available, plotting Kaplan- Meier survival curves for 
mortality after surgery in those with and without a preop-
erative cardiovascular event. Cox proportional- hazards 
model will be used to provide an estimate of the median 
endpoint ratio as well as HR.
Missing data
Missing data will be dealt with in two ways. The extent is 
expected to be generally modest with HES. We anticipate 
needing to exclude <0.1% of records with an unknown or 
invalid age, sex and length of stay following the linkage 
process. Records with unknown deprivation index will be 
assigned to a placeholder deprivation decile and retained 
for analysis. With MINAP, missing data for continuous vari-
ables will be handled using standard multiple imputation. 
For categorical variables, we will create an artificial category 
as for missing deprivation in HES.
Limitations
During the study period, four successive iterations of the 
universal definition of myocardial infarction have been 
adopted, with the potential to effect change in which 
patients are captured in HES data. Within the use of 
ICD-10 codes for HES APC, the changes in definition are 
minor, and many of the changes in the universal defini-
tions concern those surrounding myocardial injury and 
ischaemia around the time of a cardiac intervention, thus 
not meaningfully affecting the study populations’ inci-
dence of all cause myocardial infarction. We recognise 
that not all patients who have had a cardiovascular event 
will have presented to an English hospital or received 
inpatient care.
The data granularity of HES precludes absolute differ-
entiation of whether the postoperative myocardial infarc-
tions were type 1 (coronary artery disease related) or type 
2 (related to a supply/demand imbalance).
Clinical management of ACSs and strokes has evolved 
over this time: particularly, wider access to primary 
percutaneous coronary intervention for STEMI and 
endovascular clot retrieval in strokes. At the same time, 
perioperative management of patients with a previous 
vascular event has also progressed over this time as the 
evidence on the perioperative management of anticoagu-
lants and antiplatelets changed.
Generalisability
These are patient- level national data incorporating all avail-
able non- cardiac, non- neurosurgical operations in NHS 
hospitals in England and NHS- commissioned services 
performed in private hospitals in England over a 10- year 
period. As such, these represent real- world data incorpo-
rating how evidence is applied to clinical practice, not only 
how patients within the constraints of a clinical trial may be 
managed. It will also represent analysis of the largest data set 
of perioperative MACE outcomes in patients with a history of 
ACS or CVA.
While the data sets cover England, prior work has demon-
strated concordance between Danish registries and HES 
based studies, which would suggest the results are generalis-
able to at least northern European healthcare settings.19
ETHICS AND DISSEMINATION
Formal applications for data sharing have been made to rele-
vant bodies including: research ethics committee approvals 
for the linkage of these data sets for secondary analysis of 
the data (REC reference: 18/EM0403, East Midlands—Not-
tingham 1 REC on 19/12/2018); HRA Confidentiality Advi-
sory Group (CAG) with respect to Section 251 (4) of the 
NHS Act 2006 (CAG ref: 19/CAG/0013) in order that we 
could retrieve and receive anonymised patient data from 
NHS digital and MINAP without consent from patients. 
CAG’s statutory role is to consider the feasibility of obtaining 
consent for research for what in this study will be approxi-
mately 44 million admissions. To comply with relevant 
UK/EU data protection, legislation privacy notices will be 
displayed through the organisations that hold the data and a 
mechanism for opting out will be made available for patients 
to dissent to the use of their pseudoanonymised data prior 
to linkage.
The expected output from linking these databases is the 
most robust estimate to date of any time- dependent associa-
tion between a preoperative cardiovascular event and postop-
erative MACE. Secondary analyses will stratify patients’ risk by 
the degree of surgical invasiveness and surgical specialty; the 
type of the stroke or ACS and patients with multiple preop-
erative cardiovascular events. For those with ACS, we will also 
investigate how the treatment received and pathophysiology 
at the time of their preoperative event may be predictive of 
subsequent adverse perioperative outcomes.
Reporting of the results will be through publication within 
peer- reviewed journals, posters and presentations at scientific 
and educational meetings, and to the public through online 
media so as to obtain maximal reach and inform patient 
choice as well as expanding scientific knowledge.
PATIENT INVOLVEMENT
The research topic itself has been identified as a research 
priority by the recent James Lind Alliance priority setting 
partnership, which was a coproduction between patients, 
researchers and clinicians. MINAP and NHS Digital have 
robust patient and public involvement in their approvals 
process, which is independent of the authors.
Comments were also sought from the Royal College 
of Anaesthetists’ ‘Patient, Carer and Public Involvement 
and Engagement in research’ working group, a body 
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of clinicians and members of the public; they were also 
supportive of the study.
As this study is non- intrusive, working with completely 
anonymised data and where the outcomes were already fixed 
by the nature of the databases, there was no need identified 
for further patient and public involvement.
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